Cox-2 inhibitors and cardiovascular disease: considerable heat, but not much light.
Steven E
SE
Nissen
D050197:Atherosclerosis / Q000517:prevention & control*; D000068579:Celecoxib; D023903:Coronary Restenosis / Q000517:prevention & control*; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D058426:Neointima / Q000473:pathology*; D011720:Pyrazoles / Q000008:administration & dosage*; D013449:Sulfonamides / Q000008:administration & dosage*
D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib